Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease

Thyroid

Volumn 9, Issue 2, 1999, Pages 149-153

  Hidaka, Yoh ^a   Okumura, Motoshi ^a   Fukata, Shuji ^b   Shimaoka, Yuki ^a   Takeoka, Keiko ^a   Tada, Hisato ^a   Kuma, Kanji ^b   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ARTICLE; AUTOIMMUNITY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0032968235     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.149     Document Type: Article

References (15)

1. Mosmann TR, Sad S 1996 The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
2. Dayan CM, Daniels GH 1996 Chronic autoimmune thyroiditis. N Engl J Med 335:99-107.
3. Prabhakar BS, Fan JL, Seetharamaiah GS 1997 Thyrotropin-receptor-mediated diseases: A paradigm for receptor autoimmunity. Immunol Today 18:437-442.
4. Hidaka Y, Okumura M, Shimaoka Y, Takeoka K, Tada H, Amino N 1998 Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis. Thyroid 8:235-239.
5. Trinchieri G 1995 Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276.
6. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K 1987 Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. J Clin Endocrinol Metab 65:324-330.
7. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S 1993 Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199-1204.
8. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P 1994 The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237.
9. Germann T, Szeliga J, Hess H, Storkel S, Podlaski FJ, Gately MK, Schmitt E, Rude E 1995 Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci USA 92:4823-4827.
10. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L 1995 Interleukin 12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821.
11. Zipris D, Greiner DL, Malkani S, Whalen B, Mordes JP, Rossini AA 1996 Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol 156:1315-1321.
12. Ajjan RA, Watson PF, Weetman AP 1997 Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 82:666-669.
13. Hidaka Y, Amino N, Iwatani Y, Kaneda T, Nasu M, Mitsuda N, Tanizawa O, Miyai K 1992 Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Autoimmunity 11:239-246.
14. Nakajima A, Hirose S, Yagita H, Okumura K 1997 Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J Immunol 158:1466-1472.
15. Bagenstose LM, SaIgame P, Monestier M 1998 IL-12 down-regulates autoantibody production in mercury-induced autoimmunity. J Immunol 160:1612-1617.